Post by
WallstreetGuru on Aug 22, 2023 7:33am
Primed for Psychedelics Leadership
With psychedelics progressing into the mainstream, LSDI built strategic advantages through its diverse pipeline and capital management excellence. Potential revenue-generating therapies and additional R&D candidates strengthen LSDI's positioning as an early category leader.
Comment by
StockAlchemy on Aug 23, 2023 9:02am
I beilieve Lucy is going to be a leader in this space too reasons why I invested here.
Comment by
WallstreetGuru on Aug 23, 2023 1:18pm
Well the company has everything going for it with the new management and the two drugs they have in the market. We just need the market to start reacting to what they are doing.